argenx SE (ARGX)
942.04
+0.79
(+0.08%)
USD |
NASDAQ |
Nov 19, 16:00
941.59
-0.45
(-0.05%)
Pre-Market: 08:02
argenx Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 19, 2026 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Autolus Therapeutics Plc | 12.70 |
| Cellectis SA | 2.412 |
| Halozyme Therapeutics, Inc. | -- |
| DBV Technologies SA | 3.984 |
| Akari Therapeutics Plc | 0.8761 |
Price to Book Value Related Metrics
| PE Ratio | 35.90 |
| PS Ratio | 11.78 |
| Price to Free Cash Flow | 56.47 |
| Price | 942.04 |
| Earnings Yield | 2.79% |
| Market Cap | 58.30B |
| Operating PE Ratio | 40.87 |
| Normalized PE Ratio | 35.90 |